Blog Archives

Understanding the Value of Medication: Whose job is it?

There has been a lot of discussion about drugs and drug pricing of late, including the idea of value-based purchasing.  One element, though, that hasn’t been getting quite enough attention is just how a patient or a pharmacist or a

Tagged with: , , , ,
Posted in Biosimilars, Health Care Costs, Pharmaceuticals

Drug Pricing: Where Are We Now?

Back in September, I mused that little was new in the drug pricing debate.  Today, while it is still true that novel solutions are not under discussion, there does seem to be new energy to the debate.  The issue has become

Tagged with: , , , ,
Posted in Health Care Costs, Pharmaceuticals

Are We Reaching a Tipping Point on Drug Prices?

Is it just me, or does it seem like there is a groundswell of concern regarding drug prices?  Is it possible that we are reaching a tipping point and the U.S. may finally act to curb abuses? Just yesterday, Senator

Tagged with: , , , , , , ,
Posted in Pharmaceuticals

Investments Needed No Matter Which Way You Turn: The Hepatitis C Dilemma

A lot of attention has been paid to Sovaldi and Harvoni this last year, with perhaps more attention given to their remarkable price tags than to their remarkable efficacy.  This is somewhat understandable as the twelve-week course of treatment of

Tagged with: , , , , ,
Posted in Medicaid, Pharmaceuticals